Article
GlaxoSmithKline's Benlysta earns first FDA approval for lupus nephritis as competitors wait in the
Rating:
0.0
Views:
45
Likes:
1
Library:
1
When GlaxoSmithKline earned its first approvals back in 2011 for Benlysta, it promised regulators it would keep the ball rolling in its pursuit of lupus nephritis, a severe form of the autoimmune disease that can cause renal failure. Now, nearly a decade after the biologic first hit the market, GSK
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value